Revolutionary VitaSmart™ HOPE System Launched at Duke University Hospital After FDA Clearance Duke University Hospital has officially implemented the VitaSmart™ Hypothermic Oxygenated Perfusion System, following its FDA clearance, marking a significant advancement in organ transplantation techniques.

Revolutionary VitaSmart™ HOPE System Launched at Duke University Hospital After FDA Clearance #USA #VitaSmart #Bridge_to_Life #Duke_University #Duke_University,_North_Carolina

Bridge to Life Secures FDA Approval for Innovative VitaSmart Hypothermic Oxygenated Perfusion System Bridge to Life has received FDA's De Novo approval for its VitaSmart hypothermic oxygenated perfusion system, revolutionizing liver transplantation.

Bridge to Life Secures FDA Approval for Innovative VitaSmart Hypothermic Oxygenated Perfusion System #USA #FDA_Approval #Duluth #VitaSmart #Bridge_to_Life

FDA Grants De-Novo Clearance for VitaSmart HOPE System for Liver Transplants Bridge to Life secures FDA approval for the VitaSmart HOPE system, marking a milestone in liver transplant preservation technology with broader clinical applicability.

FDA Grants De-Novo Clearance for VitaSmart HOPE System for Liver Transplants #United_States #Duluth #VitaSmart #Bridge_to_Life #Liver_Transplant

Bridge to Life's VitaSmart System Gains FDA Approval for Liver Transplant Preservation Bridge to Life™ Ltd. has achieved a key milestone with FDA De Novo clearance for its VitaSmart™ system, transforming liver transplant preservation practices in the U.S.

Bridge to Life's VitaSmart System Gains FDA Approval for Liver Transplant Preservation #USA #FDA_Approval #VitaSmart #Bridge_to_Life #Duluth,_Georgia

Bridge to Life Welcomes Brian Lenz as New CFO to Drive Growth and Innovation Bridge to Life Ltd has appointed Brian Lenz, an experienced finance executive, as Chief Financial Officer to enhance growth strategies, particularly for the VitaSmart™ product line.

Bridge to Life Welcomes Brian Lenz as New CFO to Drive Growth and Innovation #United_States #Chicago #VitaSmart #Bridge_to_Life #Brian_Lenz

Groundbreaking Study Confirms HOPE Method Enhances Pediatric Liver Transplant Outcomes A pioneering multicenter study reveals the safety and effectiveness of hypothermic oxygenated perfusion (HOPE) with VitaSmart™ in pediatric liver transplants, enhancing outcomes and organ preservation.

Groundbreaking Study Confirms HOPE Method Enhances Pediatric Liver Transplant Outcomes #USA #Chicago #VitaSmart #pediatric_liver #HOPE_method

Groundbreaking Multicenter Study Validates HOPE Technology for Pediatric Liver Transplantation A pioneering multicenter study on hypothermic oxygenated perfusion shows the safety and effectiveness of HOPE in pediatric liver transplants, enhancing organ viability.

Groundbreaking Multicenter Study Validates HOPE Technology for Pediatric Liver Transplantation #Germany #Berlin #VitaSmart #Pediatric_Transplant #HOPE_Technology

New Insights from Bridge to HOPE Trial Reveal Major Advances in Liver Transplantation Outcomes Recent data from the Bridge to HOPE clinical trial highlights its significant advantages in liver transplantation regarding cost, quality of care, and rejection management.

New Insights from Bridge to HOPE Trial Reveal Major Advances in Liver Transplantation Outcomes #USA #San_Francisco #VitaSmart #Liver_Transplantation #Bridge_to_HOPE

New Insights from Bridge to HOPE Study Highlight Benefits of Liver Transplantation Methodologies Recent analyses from the Bridge to HOPE study reveal significant clinical, economic, and immunomodulatory benefits for liver transplants, enhancing patient outcomes and reducing healthcare costs.

New Insights from Bridge to HOPE Study Highlight Benefits of Liver Transplantation Methodologies #USA #San_Francisco #VitaSmart #Bridge_to_HOPE #Hypothermic_Oxygenation

Innovative Study Reveals Superior Outcomes in Liver Transplantation with HOPE Technique A groundbreaking comparative study finds that Hypothermic Oxygenated Machine Perfusion (HOPE) outperforms Normothermic Machine Perfusion (NMP) in liver transplantation, enhancing survival rates.

Innovative Study Reveals Superior Outcomes in Liver Transplantation with HOPE Technique #USA #San_Francisco #VitaSmart #Liver_Transplantation #Hope

Comparative Study Reveals HOPE Outperforms NMP in Liver Transplants A groundbreaking study demonstrates that hypothermic oxygenated machine perfusion (HOPE) significantly improves transplant outcomes compared to normothermic machine perfusion (NMP).

Comparative Study Reveals HOPE Outperforms NMP in Liver Transplants #San_Francisco #VitaSmart #Hope #NMP

New Study: Hypothermic Oxygenated Perfusion Outperforms Normothermic Machine Perfusion in Liver Transplantation A recent study compares hypothermic oxygenated perfusion (HOPE) with normothermic machine perfusion (NMP) for liver transplants, showing HOPE's superiority in outcomes.

New Study: Hypothermic Oxygenated Perfusion Outperforms Normothermic Machine Perfusion in Liver Transplantation #USA #San_Francisco #VitaSmart #Bridge_to_Life #Hope

Bridge to Life Strengthens Market Position with VitaSmart Acquisition Bridge to Life Ltd. enhances its market leadership in organ preservation by acquiring the innovative VitaSmart™ system from Medica S.p.A. This strategic move aims to advance transplant medicine.

Bridge to Life Strengthens Market Position with VitaSmart Acquisition #USA #Chicago #VitaSmart #Bridge_to_Life #Medica_S.p.A

Bridge to Life Strengthens Organ Preservation with VitaSmart Acquisition Bridge to Life Ltd. has acquired the VitaSmart™ machine perfusion system, enhancing its capabilities in organ preservation and transplant medicine.

Bridge to Life Strengthens Organ Preservation with VitaSmart Acquisition #USA #Chicago #VitaSmart #Bridge_to_Life #Medica_S.p.A.

Bridge to Life Strengthens Presence in Organ Preservation with VitaSmart Acquisition Bridge to Life Ltd. has acquired the VitaSmart™ system, enhancing its position in organ preservation. This move aims to improve transplant outcomes and global access to vital technologies.

Bridge to Life Strengthens Presence in Organ Preservation with VitaSmart Acquisition #USA #Chicago #VitaSmart #Bridge_to_Life #Medica_S.p.A.